Welcome back to Meibomian Gland Adventure Land! Last month, I offered a basic definition of “best practices” vs. standard of care and then applied it to making the diagnosis of MGD. This month’s task is to do the same thing with treatment.
To review, evaporative dry eye disease (eDED) likely represents upward of 80% of diagnosable DED in the U.S. The underlying pathophysiology is either low-quantity or low-quality meibomian gland secretions, or both. This, with or without other causative contributors such as infrequent or inadequate blinking, results in an increase in the rate of tear